Flt3-mutated Acute Myeloid Leukemia

• CLINICAL_TRIALS research · 2026-03-04
  Clinical Trial Update: A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia [Phase 1, Phase 2]

  Clinical trial update for a first-line combination of gilteritinib, venetoclax, and azacitidine in newly diagnosed acute myeloid leukemia, i…

• CLINICAL_TRIALS trial_result · 2024-10-16
  Clinical Trial Update: A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia. [Phase 1, Phase 2]

  Astellas reports results from a Phase 1/2 study of ASP2215 (gilteritinib) in combination with induction and consolidation chemotherapy for n…

• FDA approval · 2022-01-12
  FDA Approved: XOSPATA — Supplemental Application (Astellas Pharma US, Inc.)

  FDA approved a supplemental application for XOSPATA (gilteritinib) submitted by Astellas Pharma US, Inc.